Latest Breaking News On - Injury incidence - Page 1 : comparemela.com

Female athletes likelier to get injured at certain points in their menstrual cycle, finds study

Female athletes likelier to get injured at certain points in their menstrual cycle, finds study
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Georgie bruinvelsJo blodgettMary universityWomen super leagueUniversity of bathInstitute of sportSuper leagueInterventional scienceSally barlowInjury incidenceMenstrual cycleFemale footballersProspective three season cohort study

Sotagliflozin May Steal the Spotlight in Heart Failure, but Questions Remain

Although newly approved, there is some debate regarding the benefits and populations in which sotagliflozin will be the most effective.

United statesLexicon pharmaceuticals incYork heart associationNew york heart associationAmerican collegeAmerican heart associationQuick factsInjury incidenceGlobal burdenDisease studyHeart failureAmerican heart association joint committeeClinical practiceLexicon pharmaceuticalsNat cardiovasc resRecent worsening heart

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers

Results presented today at ASCO 2023 and concurrently published in The Lancet Oncology demonstrate meaningful clinical benefit including antitumor activity, confirmed objective response rate

United statesBritish columbiaZymework azymetricDiana papoveJack spinksAndrean flynnRob iannoneKristin bhavnaniUniversity of texas md anderson cancer centerPrnewswire jazz pharmaceuticalsZymeworks incExchange commissionEuropean medicines agencyAmerican society of clinical oncologyCorporate communicationsSecurities exchange

Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers

Results presented today at ASCO 2023 and concurrently published in The Lancet Oncology demonstrate meaningful clinical benefit including antitumor activity,.

United statesUniversity of texasBritish columbiaAndrean flynnRob iannoneDiana papoveKristin bhavnaniJack spinksZymework azymetricUniversity of texas md anderson cancer centerAmerican society of clinical oncologyDrug administrationDepartment of gastrointestinal medical oncologySecurities exchangeCorporate communicationsJazz pharmaceuticals

Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers

Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of texasBritish columbiaJack spinksDiana papoveAndrean flynnKristin bhavnaniRob iannoneZymework azymetricZymeworks incJazz pharmaceuticalsExchange commissionCommission file noJazz pharmaceuticals irelandBeigene ltdDepartment of gastrointestinal medical oncology